Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Lancet (London, England)|June 10, 1995
Individualised low-dose alglucerase therapy for type 1 Gaucher's diseaseC E Hollak, J M Aerts, R Goudsmit, et al.The Biochemical Journal|July 1, 1990
Comparative study on glucocerebrosidase in spleens from patients with Gaucher diseaseJ M Aerts, W E Donker-Koopman, S Brul, et al.European Journal of Biochemistry|August 17, 1990
Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolaseS Van Weely, J M Aerts, M B Van Leeuwen, et al.Journal of Clinical Monitoring and Computing|April 4, 2016
Heart rate time series characteristics for early detection of infections in critically ill patientsT Tambuyzer, F Guiza, E Boonen, et al.Journal of Clinical Immunology|September 3, 1999
Activation of mononuclear cells by interleukin-12: an in vivo study in chimpanzeesF N Lauw, A A te Velde, P E Dekkers, et al.Zoonoses and Public Health|November 27, 2012
Model-based prediction of nephropathia epidemica outbreaks based on climatological and vegetation data and bank vole population dynamicsS Amirpour Haredasht, C J Taylor, P Maes, et al.European Journal of Biochemistry|March 16, 1987
Relationship between the two immunologically distinguishable forms of glucocerebrosidase in tissue extractsJ M Aerts, W E Donker-Koopman, C van Laar, et al.Biochimica Et Biophysica Acta|November 19, 2013
Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidosesMaria J Ferraz, Wouter W Kallemeijn, Mina Mirzaian, et al.Journal of Inherited Metabolic Disease|March 21, 1998
Oligosaccharide excretion in adult Gaucher diseaseJ G de Jong, J M Aerts, S van Weely, et al.The Journal of Biological Chemistry|October 3, 1998
Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidaseH S Overkleeft, G H Renkema, J Neele, et al.Pageof 8